Skip to main content
Explore URMC
URMC / Research / Clinical Trials / Study Details

UMMY18121 / Amgen Deno Smol Lipe IIT / Brea Lipe

Research Question:
Is denosumab, delivered as an injection under the skin, safe and well-tolerated in people with smoldering multiple myeloma? And can denosumab reduce the risk of getting multiple myeloma?

Basic Study Information

This study will assess the safety and tolerability of denosumab in smoldering multiple myeloma subjects as well to see if denosumab can reduce subjects' risk of getting multiple myeloma.

Location: University of Rochester Medical Center
Study Reference #: UMMY18121

Lead Researcher (Principal Investigator)

Lead Researcher:  Brea Lipe

Study Contact Information

Study Coordinator: Lauren Mitchell

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search